ArticlePharmaceutics2022

pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis.

Huiru Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.